Nia Abraham
Physician Assistant · Skokie, ILNPI 1689141806
Payments from drug & device makers
Across 289 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$560
- Novo Nordisk$512
- Amgen$504
- Lilly USA, LLC$433
- Dexcom, Inc.$298
- Sanofi-aventis U.S. LLC$276
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,899100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$121
- EVENITY$109
- GVOKE HYPOPEN$107
How this compares
$4,899 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 168 | $216,035 |
| MounjaroTirzepatide | 57 | $84,289 |
| TrulicityDulaglutide | 38 | $72,737 |
| JardianceEmpagliflozin | 61 | $72,388 |
| Tresiba Flextouch U-100Insulin Degludec | 51 | $41,893 |
| FarxigaDapagliflozin Propanediol | 31 | $36,621 |
| RybelsusSemaglutide | 20 | $36,465 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 18 | $28,259 |
| JanuviaSitagliptin Phosphate | 16 | $18,066 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 18 | $14,773 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $14,307 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 17 | $13,468 |
| Humalog Kwikpen U-100Insulin Lispro | 25 | $10,854 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $10,238 |
| Gvoke Hypopen 2-PackGlucagon | 14 | $8,806 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $512 | $252,500188 claims |
| Lilly USA, LLCMounjaro, Trulicity | $433 | $157,02695 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $183 | $87,16179 claims |
| AstraZenecaFarxiga | $145 | $36,62131 claims |
| MerckJanuvia | $36 | $18,06616 claims |
| AbbVieSynthroid | $560 | $2,58424 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $86 | $2,280238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Skokie
- Christopher AricoSkokie$407K
- Ian MackeySkokie$135K
- Kathryn ShannonSkokie$17K
- Andrew MastroChicago$419K
- Karlijn BurridgeWestmont$144K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.